# OLEMA PHARMACEUTICALS INC (OLMA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/OLMA/

- Reporting holders: 3
- Reported value: $14.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $9.7K | 1,122 | 0.0% | 8 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.8K | 555 | 0.0% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $259 | 30 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $14.7K |
| Q2 2026 | 187 | $1.4B |
| Q1 2026 | 201 | $1.6B |
| Q4 2025 | 203 | $2.3B |
| Q3 2025 | 130 | $674.5M |
| Q2 2025 | 123 | $301.4M |
| Q1 2025 | 134 | $248.2M |
| Q4 2024 | 157 | $417.1M |
| Q3 2024 | 131 | $705.7M |
| Q2 2024 | 129 | $664.3M |
| Q1 2024 | 127 | $648.3M |
| Q4 2023 | 113 | $739.0M |